{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=amphetamine&page=7", "query": { "intervention": "amphetamine", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 318, "total_pages": 32, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=amphetamine&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=amphetamine&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T00:14:31.836Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00746733", "title": "Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Lisdexamfetamine Dimesylate", "type": "DRUG" }, { "name": "Adderall XR (mixed salts amphetamine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2008-09-08", "completion_date": "2008-10-26", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00746733" }, { "nct_id": "NCT01793610", "title": "Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Posttraumatic Stress Disorder" ], "interventions": [ { "name": "Comparator Dose (40mg) MDMA HCl", "type": "DRUG" }, { "name": "Active Dose 2 (100 mg) MDMA HCl", "type": "DRUG" }, { "name": "Active Dose 1 (125 mg) MDMA HCl", "type": "DRUG" }, { "name": "Psychotherapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Resilient Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29, "start_date": "2013-05-13", "completion_date": "2017-02-01", "has_results": true, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Boulder, Colorado", "locations": [ { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01793610" }, { "nct_id": "NCT00573183", "title": "Stimulant Abuser Groups to Engage in 12-Step", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Drug Abuse" ], "interventions": [ { "name": "STAGE-12", "type": "BEHAVIORAL" }, { "name": "Treatment as Usual", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 471, "start_date": "2008-01", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 10, "location_summary": "Jacksonville, Florida • Kaneohe, Hawaii • Columbus, Ohio + 7 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Kaneohe", "state": "Hawaii" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Eugene", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573183" }, { "nct_id": "NCT02033707", "title": "Effects of Hallucinogens and Other Drugs on Mood and Performance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Hallucinogens and psychoactive substances", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "21 Years to 50 Years" }, "enrollment_count": 20, "start_date": "2014-04", "completion_date": "2019-02", "has_results": false, "last_update_posted_date": "2019-05-16", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02033707" }, { "nct_id": "NCT01235338", "title": "Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "LDX + Venlafaxine XR", "type": "DRUG" }, { "name": "Venlafaxine XR + LDX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 80, "start_date": "2010-10-28", "completion_date": "2011-01-17", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01235338" }, { "nct_id": "NCT00208143", "title": "Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Substance Abuse", "Substance Dependence" ], "interventions": [ { "name": "Quetiapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Creighton University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "19 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2003-11", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2007-12-13", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00208143" }, { "nct_id": "NCT04531176", "title": "EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes", "Obesity" ], "interventions": [ { "name": "Weight Management Program (WMP)", "type": "OTHER" }, { "name": "Traditional care", "type": "OTHER" }, { "name": "Phentermine / Topiramate Extended Release Oral Capsule", "type": "DRUG" }, { "name": "naltrexone/bupropion extended-release", "type": "DRUG" }, { "name": "liraglutide 3.0 mg", "type": "DRUG" }, { "name": "Orlistat", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 74, "start_date": "2020-09-01", "completion_date": "2023-08-04", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04531176" }, { "nct_id": "NCT00000306", "title": "Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cocaine-Related Disorders", "Opioid-Related Disorders" ], "interventions": [ { "name": "Dextroamphetamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 140, "start_date": "1994-09", "completion_date": "2001-09", "has_results": false, "last_update_posted_date": "2017-01-12", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000306" }, { "nct_id": "NCT02229214", "title": "Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Qsymia", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VIVUS LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 51, "start_date": "2014-08", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2017-11-07", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 1, "location_summary": "Lakewood, Colorado", "locations": [ { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02229214" }, { "nct_id": "NCT04278404", "title": "Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronavirus Infection (COVID-19)", "Pulmonary Arterial Hypertension", "Urinary Tract Infections in Children", "Hypertension", "Pain", "Hyperphosphatemia", "Primary Hyperaldosteronism", "Edema", "Hypokalemia", "Heart Failure", "Hemophilia", "Menorrhagia", "Insomnia", "Pneumonia", "Skin Infection", "Arrythmia", "Asthma in Children", "Bronchopulmonary Dysplasia", "Adrenal Insufficiency", "Fibrinolysis; Hemorrhage", "Attention Deficit Hyperactivity Disorder", "Multisystem Inflammatory Syndrome in Children (MIS-C)", "Kawasaki Disease", "Coagulation Disorder", "Down Syndrome" ], "interventions": [ { "name": "The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "0 Years to 20 Years" }, "enrollment_count": 5000, "start_date": "2020-03-05", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-22T00:14:31.836Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 40 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04278404" } ] }